PCV7: INCREMENTAL COST-EFFECTIVENESS RATIO IN ESTIMATION SOME HYPOTENSIVE DRUGS

Furthering benefit/risk ratio and cost effectiveness of anticancer drugs.

BACKGROUND In Russia, the incidence of melanoma is increasing steadily. The approved standard of specialized medical care for melanoma of the skin defined the range of drugs, recommended for the provision of quality health care. However, it appears that the most effective innovative and safe medicines are at the same time the most expensive drugs. The most important is the assessment of drug us...

Incremental Cost-Effectiveness (ICE) Concepts

Incremental cost-effectiveness ratio and net monetary benefit: Current use in pharmacoeconomics and future perspectives.

In evaluating the cost/effectiveness of therapeutic interventions (e.g. those based on innovative drugs or on Class-III medical devices), two main pharmacoeconomic parameters have been used over the past decades: the incremental cost-effectiveness ratio (ICER [1–3]) and the net monetary benefit (NMB [4–6]). The ICER and the NMB share some common features because they both require a pre-defined ...

Incremental cost-effectiveness of initial cataract surgery.

PURPOSE The purpose of this study was to perform a reference case, cost-utility analysis of initial cataract surgery using the current literature on cataract outcomes and complications. DESIGN Computer-based econometric modeling. METHODS Visual acuity data of patients treated and observed over a 4-month postoperative period was obtained from the US National Cataract Patient Outcomes Researc...

Incremental cost-effectiveness ratio analysis of biologic treatments for psoriasis at clinically significant evaluation time points.

The Spanish guidelines for the treatment of psoriasis recommend that drug choice should be guided by the criteria established in the Summary of Product Characteristics (SPC) for each agent and that decisions should be made on a case-by-case basis and take into account economic considerations. Since the introduction of biologic agents, several authors have studied their cost-efficacy. However, n...